Jupiter Wellness Inc Stock Price, News & Analysis

Safety Shot (NASDAQ: SHOT) has announced the pricing of a $16.3 million financing round through a combination of a registered direct offering and private placement. The company is offering 22,993,492 shares at $0.461 per share in the registered direct offering, along with warrants to purchase up to 45,986,984 shares in a concurrent private placement.

The warrants have a $0.125 purchase price, an exercise price of $0.461, and a five-year expiration term. The financing comes following shareholder approval of Safety Shot's merger with Yerbaé, with CEO Jarrett Boon stating the funds will support expanded operations and integration efforts. Dominari Securities served as the exclusive placement agent.

Safety Shot (NASDAQ:SHOT) has announced the pricing of a $10.6 million registered direct offering with an institutional investor. The offering includes 28,648,648 shares of common stock priced at $0.37 per share.

Additionally, the company issued warrants in a concurrent private placement to purchase up to 57,297,296 shares at an exercise price of $0.37 per share, exercisable immediately with a five-year expiration. The offering, expected to close around July 22, 2025, follows shareholder approval of Safety Shot's merger with Yerbaé and aims to strengthen the company's balance sheet for expanded operations.

Safety Shot (Nasdaq: SHOT) has received a 180-day extension from Nasdaq until December 29, 2025, to regain compliance with the minimum bid price requirement. The extension was granted based on the company meeting all other Nasdaq Capital Market listing requirements except the bid price requirement.

The company's stock will continue trading on Nasdaq under "SHOT" while it works to meet the minimum $1.00 bid price requirement for at least 10 consecutive business days. CEO Jarrett Boon noted that the Board has approved several strategic options to address this requirement while focusing on business strategy and Yerbaé integration.

Safety Shot (NASDAQ:SHOT) has completed its acquisition of Yerbae Brands Corp, a plant-based energy beverage company. Through this business combination, Safety Shot acquired all issued and outstanding Yerbae shares, with Yerbae shareholders receiving 0.2918 SHOT shares for each Yerbae share.

The transaction resulted in the issuance of 19,881,948 SHOT shares, with Safety Shot shareholders now owning 81.64% of the combined company and former Yerbae shareholders holding 18.36%. Yerbae shares will be delisted from TSX Venture Exchange and OTCQX effective June 30, 2025.

Safety Shot (NASDAQ: SHOT) has provided an update regarding the closing timeline of its previously announced acquisition of Yerbaé Brands Corp. (TSX-V: YERB.U). Following stockholder approval on June 12, 2025, the closing process, which was initially expected this week, has been rescheduled to next week due to holiday-related scheduling adjustments. The companies are currently finalizing the administrative steps necessary for the transaction. Maxim Group LLC is acting as Safety Shot's exclusive financial advisor for the acquisition. A detailed press release about the completed merger will be issued upon closing next week.

Safety Shot (NASDAQ: SHOT) shareholders have approved the acquisition of Yerbaé Brands Corp. (TSX-V: YERB.U), a plant-based functional beverage company. The merger is expected to close next week, with the combined company continuing to operate as Safety Shot and trading on Nasdaq under 'SHOT'. Yerbaé will be delisted from TSX Venture Exchange. The strategic combination merges Safety Shot's wellness solutions, including its Sure Shot™ rapid alcohol reducer, with Yerbaé's zero-sugar, zero-calorie energy beverages. The acquisition aims to leverage Yerbaé's retail and distribution network to accelerate growth for both brands. Maxim Group LLC serves as Safety Shot's exclusive financial advisor for the transaction.

Safety Shot (NASDAQ: SHOT), known for its blood alcohol-reducing supplement Sure Shot, announced expansion into nootropics and sleep aid markets. The company plans to leverage its expertise in rapid wellness solutions to develop cognitive enhancement and sleep improvement products. The R&D initiative builds on Sure Shot's foundational principles of boosting clarity, energy, and mood. The global nootropics market, valued at $6.5 billion, is projected to reach $14.9 billion by 2034 (8.7% CAGR), while the sleep supplements market, valued at $6.8 billion, is expected to hit $11.8 billion by 2034 (5.1% CAGR). Led by CEO Jarrett Boon and COO David Sandler, Safety Shot aims to create unique formulations focusing on efficacy and tangible results, with product prototypes expected later this year.

Safety Shot (NASDAQ: SHOT) has announced its upcoming Annual Shareholders' Meeting scheduled for June 12, 2025, at 11:00 AM EDT in a virtual format. The meeting will address several key proposals including: a share issuance related to the Yerbaé arrangement, an amendment to the 2024 equity incentive plan, approval of promissory notes issuance, authorization for up to 20 million shares to Core 4 Capital Corp, and a potential reverse stock split at a ratio between 1-for-5 and 1-for-35.

Shareholders of record as of April 28, 2025, can participate by registering at virtualshareholdermeeting.com/SHOT2025SM. The company has established dedicated voting lines (US: 844-202-6175, International: 1-239-592-3621) and urges shareholders to submit their votes via internet, telephone, or mail before the meeting.

Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF), a plant-based functional beverage company set to merge with Safety Shot Inc. (Nasdaq: SHOT), has announced its launch on TikTok Shop. This strategic move aims to enhance direct-to-consumer reach and boost sales through the platform's e-commerce capabilities.

The company plans to leverage TikTok's massive user base through partnerships with content creators, viral trends, and influencer-driven campaigns. Yerbaé's zero-sugar, zero-calorie beverages, powered by yerba mate, target health-conscious consumers. This digital expansion initiative is expected to benefit the combined company following the completion of the proposed merger with Safety Shot.